HORIZON EUROPE
Europeo
Scope:Specific challenge: The EU Joint Programming Initiative on Neurodegenerative Diseases Research, in particular Alzheimer's (JPND), was established in 2009 as the pilot of the Member State-led Joint Programming Initiatives and enables the participating EU Member States to work together on the challenge of age-related neurodegenerative diseases. JPND allows the establishment, alignment and building on of national research programmes to increase the effectiveness and impact of research efforts.
The JPND Research Strategy must now be scaled-up and synergies must be established with Horizon 2020 as was also called for by the Council in its conclusions of 8 December 2011[1]. The scope of the Research Strategy requires coordinated action not only amongst the participating countries but also with the EC for producing the necessary critical mass. Moreover, for achieving the highest impact possible, there is the need for less fragmentation, better coordination and alignment amongst the countries participating in the JPND.
Scope: Proposals should coordinate national and regional programmes for research in the area of neurodegenerative diseases research by...
ver más
Scope:Specific challenge: The EU Joint Programming Initiative on Neurodegenerative Diseases Research, in particular Alzheimer's (JPND), was established in 2009 as the pilot of the Member State-led Joint Programming Initiatives and enables the participating EU Member States to work together on the challenge of age-related neurodegenerative diseases. JPND allows the establishment, alignment and building on of national research programmes to increase the effectiveness and impact of research efforts.
The JPND Research Strategy must now be scaled-up and synergies must be established with Horizon 2020 as was also called for by the Council in its conclusions of 8 December 2011[1]. The scope of the Research Strategy requires coordinated action not only amongst the participating countries but also with the EC for producing the necessary critical mass. Moreover, for achieving the highest impact possible, there is the need for less fragmentation, better coordination and alignment amongst the countries participating in the JPND.
Scope: Proposals should coordinate national and regional programmes for research in the area of neurodegenerative diseases research by implementing a transnational call with EU co-funding resulting in grants to third parties, with a view to scale-up the implementation of the JPND Research Strategy. This call shall be defined as follows: ‘Identification of genetic, epigenetic and environmental risk and protective factors for neurodegenerative diseases’, and/or of the ‘Longitudinal cohorts in neurodegenerative disease research’ and/or of the ‘Advanced experimental models of neurodegenerative diseases’.
Proposals should also promote the strategic alignment of research activities related to neurodegenerative diseases across Europe, such as developing and aligning national research plans and strategies, making data bases more accessible and interoperable, harmonisation of measurements and methodologies, networking of already existing structures and studies, training etc.
Proposals should demonstrate the expected impact on national and transnational programmes as well as the leverage effect on European research and competitiveness, and should plan the development of key indicators for supporting this.
Proposal should implement other joint activities including training and additional joint calls without EU co-funding.
The Commission considers that proposals requesting a contribution from the EU of a minimum of EUR 5 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
Expected impact:
Funding of research proposals on a topic identified by the JPND implementation plan or by their action groups, which needs to be addressed at European level and which is complementary to topics of the EC work programmes; Leverage transnational excellent research with EU-added value in the area of neurodegenerative diseases; Increased commitment of participating countries to the implementation of the JPND SRA; Establishment and alignment of national and regional plans and initiatives on neurodegenerative diseases; Strengthened exchange and better interoperability between existing European infrastructures and data bases; Enhancement and/or better exploitation of national or EC-supported activities. Type of action: ERA-NET Co-fund
Cross-cutting Priorities:ERA-NET
ver menos
Características del consorcio
:
La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Características del Proyecto
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Características de la financiación
1. List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding to support its participation in projects supported under all topics in calls under the Societal Challenge ‘Health, demographic change and well-being’.
2. Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme
3. Evaluation
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme
3.2 Guide to the submission and evaluation process
4. Proposal page limits and layout: Please refer to Part B of the standard proposal template.
5. Indicative timetable for evaluation and grant agreement:
Information on the outcome of one-stage evaluation: maximum 5 months from the final date for submission.
Signature of grant agreements: maximum 3 months from the date of informing successful applicants.
6. Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
ERANET Cofund:
Specific provisions and funding r... Please read carefully all provisions below before the preparation of your application.
1. List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding to support its participation in projects supported under all topics in calls under the Societal Challenge ‘Health, demographic change and well-being’.
2. Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme
3. Evaluation
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme
3.2 Guide to the submission and evaluation process
4. Proposal page limits and layout: Please refer to Part B of the standard proposal template.
5. Indicative timetable for evaluation and grant agreement:
Information on the outcome of one-stage evaluation: maximum 5 months from the final date for submission.
Signature of grant agreements: maximum 3 months from the date of informing successful applicants.
6. Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
ERANET Cofund:
Specific provisions and funding rates
Standard proposal template (administrative forms and structure of technical annex)
Standard evaluation form
Annotated Model Grant Agreement
7. Additional provisions:
Horizon 2020 budget flexibility
Classified information
8. Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Información adicional de la convocatoria
Otras ventajas
Ayudas Similares
| Abierta
| Próximamente
| Abierta